Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31728158 | 0.80 | — | — | |
| SCHEMBL12507686 | 0.74 | NPC1 (0.49) | NPC1ALDH1A1KDM4EMAPTRAB9A | |
| SCHEMBL30133998 | 0.72 | NPC1 (0.50) | NPC1ALDH1A1KDM4EMAPTRAB9A | |
| SCHEMBL29911994 | 0.70 | NPC1 (0.47) | NPC1ALDH1A1KDM4EMAPTRAB9A | |
| SCHEMBL29186951 | 0.68 | L3MBTL1 (0.31) | — | |
| SCHEMBL29186952 | 0.68 | L3MBTL1 (0.31) | — | |
| SCHEMBL12507379 | 0.68 | NPC1 (0.45) | NPC1ALDH1A1KDM4EMAPTRAB9A | |
| SCHEMBL31352136 | 0.63 | — | — | |
| SCHEMBL25236851 | 0.63 | — | — | |
| SCHEMBL30069478 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025235874-A1 | HETEROCYCLICS AS EGFR INHIBITORS | SCHRÖDINGER, INC. (US) | 2025-11-13 | — | — | WO | disclosed |